Olga Marshall1, Hanzhang Lu2, Jean-Christophe Brisset1, Feng Xu2, Peiying Liu2, Joseph Herbert3, Robert I Grossman1, Yulin Ge1. 1. Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York. 2. Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas. 3. Department of Neurology, Multiple Sclerosis Comprehensive Care Center, New York University School of Medicine, New York.
Abstract
IMPORTANCE: Cerebrovascular reactivity (CVR) is an inherent indicator of the dilatory capacity of cerebral arterioles for a vasomotor stimulus for maintaining a spontaneous and instant increase of cerebral blood flow (CBF) in response to neural activation. The integrity of this mechanism is essential to preserving healthy neurovascular coupling; however, to our knowledge, no studies have investigated whether there are CVR abnormalities in multiple sclerosis (MS). OBJECTIVE: To use hypercapnic perfusion magnetic resonance imaging to assess CVR impairment in patients with MS. DESIGN, SETTING, AND PARTICIPANTS: A total of 19 healthy volunteers and 19 patients with MS underwent perfusion magnetic resonance imaging based on pseudocontinuous arterial spin labeling to measure CBF at normocapnia (ie, breathing room air) and hypercapnia. The hypercapnia condition is achieved by breathing 5% carbon dioxide gas mixture, which is a potent vasodilator causing an increase of CBF. MAIN OUTCOMES AND MEASURES: Cerebrovascular reactivity was calculated as the percent increase of normocapnic to hypercapnic CBF normalized by the change in end-tidal carbon dioxide, which was recorded during both conditions. Group analysis was performed for regional and global CVR comparison between patients and controls. Regression analysis was also performed between CVR values, lesion load, and brain atrophy measures in patients with MS. RESULTS: A significant decrease of mean (SD) global gray matter CVR was found in patients with MS (3.56 [0.81]) compared with healthy controls (5.08 [1.56]; P = .001). Voxel-by-voxel analysis showed diffuse reduction of CVR in multiple regions of patients with MS. There was a significant negative correlation between gray matter CVR and lesion volume (R = 0.6, P = .004) and a significant positive correlation between global gray matter CVR and gray matter atrophy index (R = 0.5, P = .03). CONCLUSIONS AND RELEVANCE: Our quantitative imaging findings suggest impairment in functional cerebrovascular pathophysiology, by measuring a diffuse decrease in CVR, which may be the underlying cause of neurodegeneration in MS.
IMPORTANCE: Cerebrovascular reactivity (CVR) is an inherent indicator of the dilatory capacity of cerebral arterioles for a vasomotor stimulus for maintaining a spontaneous and instant increase of cerebral blood flow (CBF) in response to neural activation. The integrity of this mechanism is essential to preserving healthy neurovascular coupling; however, to our knowledge, no studies have investigated whether there are CVR abnormalities in multiple sclerosis (MS). OBJECTIVE: To use hypercapnic perfusion magnetic resonance imaging to assess CVR impairment in patients with MS. DESIGN, SETTING, AND PARTICIPANTS: A total of 19 healthy volunteers and 19 patients with MS underwent perfusion magnetic resonance imaging based on pseudocontinuous arterial spin labeling to measure CBF at normocapnia (ie, breathing room air) and hypercapnia. The hypercapnia condition is achieved by breathing 5% carbon dioxide gas mixture, which is a potent vasodilator causing an increase of CBF. MAIN OUTCOMES AND MEASURES: Cerebrovascular reactivity was calculated as the percent increase of normocapnic to hypercapnic CBF normalized by the change in end-tidal carbon dioxide, which was recorded during both conditions. Group analysis was performed for regional and global CVR comparison between patients and controls. Regression analysis was also performed between CVR values, lesion load, and brain atrophy measures in patients with MS. RESULTS: A significant decrease of mean (SD) global gray matter CVR was found in patients with MS (3.56 [0.81]) compared with healthy controls (5.08 [1.56]; P = .001). Voxel-by-voxel analysis showed diffuse reduction of CVR in multiple regions of patients with MS. There was a significant negative correlation between gray matter CVR and lesion volume (R = 0.6, P = .004) and a significant positive correlation between global gray matter CVR and gray matter atrophy index (R = 0.5, P = .03). CONCLUSIONS AND RELEVANCE: Our quantitative imaging findings suggest impairment in functional cerebrovascular pathophysiology, by measuring a diffuse decrease in CVR, which may be the underlying cause of neurodegeneration in MS.
Authors: Ze Wang; Geoffrey K Aguirre; Hengyi Rao; Jiongjiong Wang; María A Fernández-Seara; Anna R Childress; John A Detre Journal: Magn Reson Imaging Date: 2007-09-10 Impact factor: 2.546
Authors: Reinoud P H Bokkers; Matthias J P van Osch; Catharina J M Klijn; L Jaap Kappelle; Jeroen Hendrikse Journal: J Neurol Neurosurg Psychiatry Date: 2011-03-08 Impact factor: 10.154
Authors: Sina Aslan; Feng Xu; Peiying L Wang; Jinsoo Uh; Uma S Yezhuvath; Matthias van Osch; Hanzhang Lu Journal: Magn Reson Med Date: 2010-03 Impact factor: 4.668
Authors: Meng Law; Amit M Saindane; Yulin Ge; James S Babb; Glyn Johnson; Lois J Mannon; Joseph Herbert; Robert I Grossman Journal: Radiology Date: 2004-06 Impact factor: 11.105
Authors: W Rashid; L M Parkes; G T Ingle; D T Chard; A T Toosy; D R Altmann; M R Symms; P S Tofts; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2004-09 Impact factor: 10.154
Authors: S Chawla; Y Ge; H Lu; O Marshall; M S Davitz; G Fatterpekar; B J Soher; O Gonen Journal: AJNR Am J Neuroradiol Date: 2015-08-20 Impact factor: 3.825
Authors: Nicholas A Hubbard; Monroe Turner; Joanna L Hutchison; Austin Ouyang; Jeremy Strain; Larry Oasay; Saranya Sundaram; Scott Davis; Gina Remington; Ryan Brigante; Hao Huang; John Hart; Teresa Frohman; Elliot Frohman; Bharat B Biswal; Bart Rypma Journal: J Cereb Blood Flow Metab Date: 2015-11-09 Impact factor: 6.200
Authors: Jeremy Deverdun; Arthur Coget; Xavier Ayrignac; Clarisse Carra-Dalliere; Alexandre Krainik; Aude Metzger; Pierre Labauge; Nicolas Menjot de Champfleur; Emmanuelle Le Bars Journal: Brain Topogr Date: 2021-01-23 Impact factor: 3.020
Authors: P Belov; D Jakimovski; J Krawiecki; C Magnano; J Hagemeier; L Pelizzari; B Weinstock-Guttman; R Zivadinov Journal: AJNR Am J Neuroradiol Date: 2017-12-07 Impact factor: 3.825